Plasma testosterone levels in hypogonadal individuals treated with Androgel, impact of showering shortly after application.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26902

Enrollment

Registered

2008-12-12

Start date

2009-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

testosterone transfer

Interventions

Regimen A: androgel 50 mg daily after showering

Regimen B: androgel 50 mg 15 minutes before showering

Regimen C: androgel 50 mg 30 minutes before showering.

Eligibility

Inclusion criteria

Inclusion criteria: Female to male transsexual after orchiectomy.

Exclusion criteria

Exclusion criteria: 1. skin conditions; 2. known intolerance for Androgel.

Design outcomes

Primary

Measure	Time frame
Maximal plasma testosterone concentration, AUC and time average concentration on day 7 of each treatment regime.	—

Contacts

Public ContactJ.T. Dissel, van

Leids Universitair Medisch Centrum Postbus 9600

j.t.van_dissel@lumc.nl+31715262613

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)